10.1016/j.exger.2013.02.009 Exp
The typical starting dose is 0.25 mg, which is gradually increased to 1 mg over a few weeks to minimize side effects and enhance tolerance
The enhanced blood flow during rewarming may improve peptide distribution
Important safety information: These medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Sainsbury K, Evans EH, Pedersen S, Marques MM, Teixeira PJ, Lhteenmki L, et al
Semaglutide is a GLP-1 receptor agonist , a medication that mimics the effects of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)